Kidney Diseases Clinical Trial
Official title:
The Effects of Hormone Therapy on Renal Hemodynamic Function in Transgender Youth
The purpose of this study is to understand the effects of testosterone or estradiol on kidney function in transgender adolescents and young adults.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 30, 2023 |
Accepts healthy volunteers | |
Gender | All |
Age group | 17 Years to 30 Years |
Eligibility | Inclusion Criteria: - Identify as transgender - Age 17-30 years (inclusive) - Plan to start gender affirming hormone therapy (testosterone or estradiol) clinically in = 1 months and remain on for at least 3 months Exclusion Criteria: - Cognitive, psychiatric or physical impairment resulting in inability to tolerate the study procedures (e.g. intellectual disability, schizophrenia, hallucinations) - Type 1 or Type 2 diabetes - Chronic kidney disease, or eGFR <60ml/min/1.73m2 by CKD-EPI formulation - Uncontrolled hypertension (resting BP = 140/90 mm/Hg) - Allergy to shellfish, iodine or iohexol - Currently taking: sulfonamides, procaine, thiazolesulfone and probenecid (renal clearance measurements of PAH cannot be made accurately if individuals are on these medications) - Prior gender affirming hormone therapy use - Prior gonadectomy - Pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital Colorado | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in measured glomerular filtration rate (GFR) | Baseline, 3 months | ||
Secondary | Change in effective renal plasma flow | Baseline, 3 months | ||
Secondary | Change in biomarkers of tubular injury and repair (Neutrophil gelatinase-associated lipocalin [NGAL], Kidney injury molecule-1 [KIM-1], Chitinase-3-like protein 1 [YKL-40]) | Baseline, 3 months | ||
Secondary | Change in fat mass | Quantified noninvasively by ImpediMed SFB7 single channel, tetra polar bioimpedance spectroscopy | Baseline, 3 months | |
Secondary | Change in fat-free mass | Quantified noninvasively by ImpediMed SFB7 single channel, tetra polar bioimpedance spectroscopy | Baseline, 3 months | |
Secondary | Change in intracellular fluid | Quantified noninvasively by ImpediMed SFB7 single channel, tetra polar bioimpedance spectroscopy | Baseline, 3 months | |
Secondary | Change in extracellular fluid | Quantified noninvasively by ImpediMed SFB7 single channel, tetra polar bioimpedance spectroscopy | Baseline, 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03246984 -
VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ
|
N/A | |
Completed |
NCT03545113 -
Graft-first Versus Fistula-first in Older Patients With End-stage Kidney Disease
|
N/A | |
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT04559321 -
Holmium Vs Trilogy Kidney Stones GUY's 1-2
|
Phase 3 | |
Recruiting |
NCT05036850 -
China Kidney Patient Trials Network
|
||
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Active, not recruiting |
NCT01529658 -
Renal Hypothermia During Partial Nephrectomy
|
N/A | |
Completed |
NCT01679587 -
Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
|
Phase 1 | |
Completed |
NCT01155141 -
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
|
Phase 4 | |
Completed |
NCT00755690 -
Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease
|
N/A | |
Recruiting |
NCT05759754 -
Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease
|
N/A | |
Completed |
NCT03213158 -
Ixazomib for Desensitization
|
Phase 2 | |
Active, not recruiting |
NCT02237352 -
Mechanisms of Diabetic Nephropathy in Ecuador
|
||
Recruiting |
NCT06067867 -
Kidney and Pregnancy Registry
|
||
Recruiting |
NCT04110080 -
Enhanced Recovery After Surgery in Kidney Transplant Donors
|
N/A | |
Active, not recruiting |
NCT04876963 -
HOLT-ED: Holter-monitoring in End-stage Renal Disease
|
||
Enrolling by invitation |
NCT05324878 -
Honoring Individual Goals and Hopes: Implementing Advance Care Planning for Persons With Kidney Disease on Dialysis
|
||
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Active, not recruiting |
NCT04631965 -
Healthcare Transition of Adolescents With Chronic Health Conditions
|
||
Completed |
NCT03394859 -
Electronic Medical Records and Genomics (eMERGE) Phase III
|